Current scenario on non-nucleoside reverse transcriptase inhibitors (2018-present) - ScienceDirect

$ 21.99 · 5 (494) · In stock

The Nucleoside Reverse Transcriptase Inhibitors, Nonnucleoside

p53 and p53-related mediators PAI-1 and IGFBP-3 are downregulated

Synthesis and biological evaluation of dihydroquinazoline-2-amines

Indolylarylsulfones bearing phenylboronic acid and phenylboronate

Picomolar inhibitor of reverse transcriptase featuring

PDF) Ultradeep sequencing of B and non-B HIV-1 subtypes: Viral

Targeting strategies for delivery of anti-HIV drugs - ScienceDirect

Current medicinal chemistry strategies in the discovery of novel

Novel indolylarylsulfone derivatives as covalent HIV-1 reverse

Current scenario on non-nucleoside reverse transcriptase

Non-nucleoside reverse transcriptase inhibitors (NNRTIs): a brief

Non-Nucleoside Reverse Transcriptase Inhibitors - an overview